Market Research Logo

Pre-Sterilized / Ready-to-Use Primary Packaging: Focus on Cartridges, Syringes and Vials, 2018-2030

Pre-Sterilized / Ready-to-Use Primary Packaging: Focus on Cartridges, Syringes and Vials, 2018-2030

INTRODUCTION
Pharmaceutical packaging plays a key role in ensuring the sterility and quality of a drug product, while providing information related to its identity and, in certain cases, dosing instructions as well. Primary packaging, owing to the fact that it is in direct contact with the drug / therapy, is considered to be critical to the preservation of the product’s stability, efficacy and safety. Further, given the growing complexity of modern pharmacological interventions, especially biologics, it has become imperative for drug / therapy packaging considerations to be reevaluated, taking into consideration the evident shift from large batches of one remedy for everyone to smaller batches of more personalized treatment options. In addition to optimizing drug-packaging compatibility, stakeholders in the pharmaceutical packaging industry have adopted a number of other flexible solutions to reduce overall cost and expedite time to market.

The use of ready-to-use (RTU), or pre-sterilized / pre-treated, container-closure systems have emerged as a promising alternative to conventional primary packaging, adding significant value to streamline pharmaceutical fill / finish operations. These packaging components eliminate multiple steps in the overall fill / finish process (mainly washing, sterilizing and preparing containers), thereby, helping improve operational efficiencies in compliance to existing regulatory standards. Owing to several other benefits, RTU container-closure systems have gradually gained popularity in the pharmaceutical industry. Moreover, many drug product manufacturers and fill / finish service providers have also adopted such systems to better serve their clients. In the future, as drug developers continue to strive to achieve greater flexibility in their operational protocols, RTU containers and closure systems are expected to play a key role.

SCOPE OF THE REPORT
The ‘Pre-Sterilized / Ready-to-Use Primary Packaging: Focus on Cartridges, Syringes and Vials, 2018-2030’ report offers a comprehensive study of the current scenario and future potential of the RTU primary packaging components market. The study features an in-depth analysis, highlighting the various types of containers that are available in the aforementioned format, including cartridges, syringes and vials, and their respective closure systems (such as stoppers, needle shields and plungers). In addition to other elements, the study includes:

A detailed assessment of the current market landscape of containers and closures that are available in the RTU format, featuring information on the companies that manufacture such products, their respective scale(s) of production, material(s) used for fabricating such components, packaging formats and affiliated fill volumes.

laborate profiles of key players in this domain; each profile features an overview of the company, its financial details, recent developments and a comprehensive future outlook.

An analysis of the partnerships that have been established in this domain in the recent past, covering acquisitions, supply agreements, product development agreements, licensing agreements and other relevant deals established in the period between 2011 and 2018.

An elaborate discussion on upcoming trends in the pharmaceutical industry that are likely to have an impact on the adoption of RTU container-closure systems.

A case study on the use of robots / robotics-based technologies in pharmaceutical manufacturing and fill / finish operations, along with profiles of industry players offering such equipment for handling RTU systems.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the market. Based on various parameters, such as target consumer segments, likely adoption rates and expected pricing, we have provided an informed estimate of the financial evolution of the market in the short and long terms, for the period 2018-2030. To account for the uncertainties associated with the adoption of RTU components and to add robustness to our predictions, we have provided three scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution. The research, analysis and insights presented in this report are backed by a deep understanding of insights gathered both from secondary and primary sources. All actual figures have been sourced and analyzed from publicly available information forums. Financial figures mentioned in this report are in USD, unless otherwise specified.

EXAMPLE HIGHLIGHTS
1. Currently, over 45 players are actively involved in providing RTU containers and / or closures, or equipment and services for RTU components. More than 50% of these players are based in Europe. Examples of recently established companies based in this region include (in alphabetical order, no selection criteria) ARaymond Life, Aseptic Technologies, Bio Elpida, Disposable Lab and Zellwag Pharmtech.

2. The market for RTU packaging components is fragmented, featuring a mix of small-sized, mid-sized and large players. Presently, the more established stakeholders hold the majority share in the industry, offering multiple types of packaging products. Examples include players (in alphabetical order, no selection criteria) Aptar Pharma, Becton Dickinson, BioPharma Solutions, Daikyo Seiko, Gerresheimer and SCHOTT.

3. More than 70 primary packaging containers and / or closures are available in the RTU format. Around 50% of the products that we came across are RTU closures, while 35% are containers. Further, nearly 20% of the components are available as a combination of containers and their affiliated closures.

4. Close to 40% of the partnership agreements inked in the period between 2011 to 2018 were acquisitions. Most recently, in 2018, CSP Technologies and Triveni Polymer were acquired by Aptar Pharma and Gerresheimer, respectively. Other partnership models adopted by companies include supply agreements, product development agreements, licensing agreements and distribution agreements.

5. Driven by the rising demand for flexible fill / finish solutions and various initiatives to automate such operations, we expect the market for RTU packaging components to grow at an annualized rate of 11.9% till 2030. Owing to the rise in personalized therapeutics, RTU syringes are anticipated to witness the highest growth rate over the forecasted period.

6. The majority share of the revenues (close to 70%) is likely to be occupied by North America and Europe; however, we believe that Asia Pacific region will grow at a faster rate of 14% as compared to other geographies over the next decade; this is attributed to the availability of low cost labor (ideal for large scale manufacturing operations), as well the growing demand for high quality packaging components in this region.

RESEARCH METHODOLOGY
The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews with experts in the area (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include
Annual reports
Investor presentations
SEC filings
Industry databases
News releases from company websites
Government policy documents
Industry analysts’ views

While the focus has been on forecasting the market over the coming twelve years, the report also provides our independent view on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

CHAPTER OUTLINES
Chapter 2 provides an executive summary of the insights captured during our research. It offers a high-level view on the current state of the market of RTU primary packaging components and its likely evolution in the long term.

Chapter 3 provides a general overview of the various types of RTU packaging containers and closures, highlighting their benefits over conventional primary packaging solutions and the growing demand for such alternatives in the pharmaceutical fill / finish operations. In addition, the chapter includes a discussion on innovation in pharmaceutical packaging industry and the growth of flexible fill / finish solutions.

Chapter 4 provides a comprehensive review of the current market landscape of RTU primary packaging components and the associated handling equipment. The chapter features details on packaging components, such as information on the manufacturers of such products, fill volumes of various types of containers, material(s) used for fabricating such components, and packaging formats. In addition, with regard to RTU package processing, the chapter includes information on the manufacturers of such equipment, type of operations supported by the machinery, type(s) of packaging components processed, fill / finish capacity and compliance certifications.

Chapter 5 includes detailed profiles of active players that are involved in providing packaging components in the RTU format. Each profile features an overview of the company, its financial details, recent developments and a comprehensive future outlook.

Chapter 6 features an elaborate discussion and analysis of the various collaborations and partnerships that have been inked amongst various stakeholders in this domain. In this section, we have also described the different partnership models (including acquisitions, supply agreements, product development agreements, licensing agreements and other agreements) adopted by collaborating entities, highlighting the most common forms of deals / agreements that have been established in the period between 2011 to 2018.

Chapter 7 discusses the key trends in the pharmaceutical manufacturing industry impacting the adoption of the RTU components. Specifically, it features brief discussion on focus on personalized therapies, shift towards more flexible packaging, improvements in packaging components for enhanced safety profiles and increase in partnerships between various industry players, among others.

Chapter 8 features an elaborate case study, presenting information on the role of robots / robotics-based technologies in the pharmaceutical manufacturing and fill / finish process. It features a list of the various types of pharmaceutical robots, along with details on their respective manufacturer(s) and their applications. Further, the chapter includes profiles of players that offer robotic machinery for pharmaceutical manufacturing and fill / finish, along with key specifications of such products.

Chapter 9 presents a comprehensive market forecast analysis, highlighting the future potential of the market till the year 2030. It includes future sales projections of various packaging components (cartridges, syringes, vials and closures). The sales potential and growth opportunity were estimated based on the current demand for respective packaging components, likely adoption rates and the estimated price of components. The chapter also presents a detailed segmentation on the basis of type of packaging component, material(s) used for fabrication (glass and plastic) and geography (the US, Europe, Asia Pacific and the rest of the world).

Chapter 10 is a summary of the overall report. In this chapter, we have provided a list of key takeaways from the report, expressing our independent opinion related to the research and analysis described in the previous chapters.

Chapter 11 includes an interview transcript of a discussion that was held with a key stakeholder in this market. It provides details of the interview conducted with Konstantin Kazarian (Business Development Project Manager, PYRAMID Laboratories).

Chapter 12 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 13 is an appendix, which provides the list of companies and organizations mentioned in the report.

LIST OF COMPANIES AND ORGANIZATIONS

The following companies and organizations have been mentioned in the report.
1. ABB
2. ACIC Pharmaceutical Machinery
3. Afton Scientific
4. Allergy Laboratories
5. Amatsigroup
6. Amgen
7. AMRI
8. APG Europe
9. AptarGroup
10. ARaymond LIFE
11. Aseptic Technologies
12. Automated Systems of Tacoma
13. Balda
14. Becton Dickinson
15. Berkshire Sterile Manufacturing
16. Bespak
17. Bio Elpida
18. BioNTech
19. BioPharma Solutions
20. Black Frame Advisors
21. Bosch Packaging Technology
22. Carl Zeiss Foundation
23. Catalent
24. Centor
25. Chinergy
26. Colanar Innovative Solutions
27. Cook Pharmica
28. Corning
29. CSP Technologies
30. Daikyo Seiko
31. Dara Pharmaceutical Packaging
32. Datwyler Group
33. DENSO
34. Disposable Lab
35. DSM Hydrocolloids
36. DWK Life Sciences
37. Eisai
38. EMA Pharmaceuticals
39. Enable Injections
40. FANUC America
41. Fedegari Group
42. Franz Ziel
43. Gerresheimer
44. Getinge Group
45. GF
46. groninger
47. Harikrushna Technopride Engg
48. IMA
49. InnoScan
50. Insulet
51. Jiamusi Electric Machine
52. Kali Care
53. Kawasaki Heavy Industries
54. Klenzaids Contamination Controls
55. KUKA
56. Lifecore Biomedical
57. MAR
58. Marchesini Group
59. Martin Christ
60. Megaplast
61. Merit Medical
62. MilliporeSigma
63. Mitsubishi Electric
64. NanoPass Technologies
65. Ningbo Zhengli Pharmaceutical Packaging
66. Nipro PharmaPackaging
67. Noble
68. Ompi
69. OMRON Industrial Automation
70. OPTIMA
71. Optrel
72. Ott
73. Pall Life Sciences
74. Paragon Bioservices
75. Pharmapak Technologies
76. Prince Sterilization Services
77. Propeller Health
78. Prysmian Group
79. Pyramid Laboratories
80. Rommelag Group
81. SCHOTT
82. Seiko Epson
83. Sensile Medical
84. SiO2 Medical Products
85. SKAN
86. Spami
87. Staubli
88. STERIGENE
89. Steriline
90. Stevanato Group
91. SVM Automatik
92. Transcoject
93. Triveni Polymer
94. Universal Robots
95. Vanrx Pharmasystems
96. Vetter Pharma
97. West Pharmaceutical Services
98. Yaskawa Electric
99. Zellwag Pharmtech
100. Zhejiang Crystal-Optech
101. Zhejiang Crystal-SCHOTT Optical Technology


1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Pharmaceutical Packaging
3.2.1. Necessity of Pharmaceutical Packaging
3.2.2. Types of Packaging
3.2.3. Innovation in Pharmaceutical Packaging
3.2.4. Pharmaceutical Filling
3.2.5. Limitations of Traditional Primary Packaging
3.3. Ready-to-Use Primary Packaging
3.3.1. Advantages of Ready-to-Use Primary Packaging
3.3.2. Current Demand for Ready-to-Use Primary Packaging and Key Enablers
3.4. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Ready-to-Use Primary Packaging: Overall Landscape
4.3. Ready-to-Use Primary Packaging: List of Products
4.3.1 Ready-to-Use Primary Packaging: Landscape Analysis
4.3.1.1. Analysis by Type of Product
4.3.1.2. Analysis by Geographical Location of Manufacturer
4.3.1.3. Analysis by Scale of Production
4.3.2. Ready-to-Use Containers
4.3.2.1. Analysis by Type of Container
4.3.2.2. Analysis by Fabrication Material
4.3.3. Ready-to-Use Closures
4.3.3.1. Analysis by Type of Compatible Container
4.3.3.2. Analysis by Sterilization Method
4.3.4. Ready-to-Use Container-Closure Systems
4.3.4.1. Analysis by Type of Container
4.3.4.2. Analysis by Fabrication Material of Containers
4.4. Ready-to-Use Package Processing Equipment: List of Products
4.4.1. Analysis by Geographical Location of Manufacturer
4.4.1.1. Analysis by Type of Equipment
4.4.1.2. Analysis by Type of Container
4.5. Ready-to-Use Packaging Fill / Finish Service Providers
5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Aptar Pharma
5.2.1. Company Overview
5.2.2. Financial Information
5.2.3. Product Portfolio
5.2.4. Future Outlook
5.3. Gerresheimer Group
5.3.1. Company Overview
5.3.2. Financial Information
5.3.3. Product Portfolio
5.3.4. Recent Developments
5.3.5. Future Outlook
5.4. Ningbo Zhengli Pharmaceutical Packing
5.4.1. Company Overview
5.4.2. Financial Information
5.4.3. Product Portfolio
5.4.4. Future Outlook
5.5. Nipro PharmaPackaging
5.5.1. Company Overview
5.5.2. Financial Information
5.5.3. Product Portfolio
5.5.4. Future Outlook
5.6. Ompi
5.6.1. Company Overview
5.6.2. Product Portfolio
5.6.3. Recent Developments
5.6.4. Future Outlook
5.7. SCHOTT
5.7.1. Company Overview
5.7.2. Financial Information
5.7.3. Product Portfolio
5.7.4. Recent Developments
5.7.5. Future Outlook
5.8. West Pharmaceutical Services
5.8.1. Company Overview
5.8.2. Financial Information
5.8.3. Product Portfolio
5.8.4. Recent Developments
5.8.5. Future Outlook
6. PARTNERSHIPS AND COLLABORATIONS
6.1. Chapter Overview
6.2. Partnership Models
6.3. Ready-to-Use Primary Packaging: List of Partnerships
6.3.1. Analysis by Year of Partnership
6.3.2. Analysis by Type of Partnership
6.3.3. Analysis by Focus Area
6.3.4. Most Active Players: Analysis by Number of Partnerships
7. UPCOMING TRENDS IN PHARMACEUTICAL PACKAGING
7.1. Chapter Overview
7.2. Shift to Self-Medication Options using Drug Delivery Devices
7.3. Development of Improved Packaging Components and Efforts to Optimize Manufacturing Costs
7.4. Availability of Modular Facilities
7.5. Advent of Personalized Therapies and Provisions for Automating Fill / Finish Operations
7.6. Increase in Partnership Activity
7.7. Increasing Activity in Developing Regions
7.8. Concluding Remarks
8. CASE STUDY: ROBOTS IN PHARMACEUTICAL PACKAGING
8.1. Chapter Overview
8.2. Role of Robots in Pharmaceutical Industry
8.2.1. Advantages of Robotic Systems
8.2.2. Disadvantages of Robotic Systems
8.3. Companies Providing Robots to the Pharmaceutical Industry
8.4. Companies using Robotic Systems for Pharmaceutical Packaging
8.4.1. Aseptic Technologies
8.4.2. AST
8.4.3. Bosch Packaging Technology
8.4.4. Dara Pharmaceutical Packaging
8.4.5. Fedegari Group
8.4.6. IMA
8.4.7. Steriline
8.4.8. Vanrx Pharmasystems
9. MARKET FORECAST AND OPPORTUNITY ANALYSIS
9.1. Chapter Overview
9.2. Forecast Methodology
9.3. Global Ready-to-Use Primary Packaging Market, 2018-2030
9.4. Global Ready-to-Use Primary Packaging Market: Distribution by Type of Fabrication Material
9.4.1. Ready-to-Use Primary Packaging Market: Share of Plastic Packaging
9.4.2. Ready-to-Use Primary Packaging Market: Share of Glass Packaging
9.5. Global Ready-to-Use Primary Packaging Market: Distribution by Geography
9.5.1. Ready-to-Use Primary Packaging Market: US Market Share
9.5.2. Ready-to-Use Primary Packaging Market: Europe Market Share
9.5.3. Ready-to-Use Primary Packaging Market: Asia Pacific Market Share
9.5.4. Ready-to-Use Primary Packaging Market: Share of the Rest of the World
9.6. Global Ready-to-Use Primary Packaging Market: Distribution by Type of Product
9.6.1. Ready-to-Use Primary Packaging Market: Share of Cartridges
9.6.1.1. Share of Ready-to-Use Cartridges: Distribution by Fabrication Material
9.6.1.2. Share of Ready-to-Use Cartridges: Distribution by Geography
9.6.2. Ready-to-Use Primary Packaging Market: Share of Syringes
9.6.2.1. Share of Ready-to-Use Syringes: Distribution by Fabrication Material
9.6.2.2. Share of Ready-to-Use Syringes: Distribution by Geography
9.6.3. Ready-to-Use Primary Packaging Market: Share of Vials
9.6.3.1. Share of Ready-to-Use Vials: Distribution by Fabrication Material
9.6.3.2. Share of Ready-to-Use Vials: Distribution by Geography
9.6.4. Ready-to-Use Primary Packaging Market: Share of Closures
9.6.4.1. Share of Ready-to-Use Closures: Distribution by Geography
10. CONCLUSION
10.1. The Pharmaceutical Industry is Witnessing an Increasing Need for Flexible Packaging Solutions
10.2. The Landscape is Dominated by the Presence of Large Players Based in the Regions of Europe and North America
10.3. Recent Advances are Expected to Act as Key Enablers for the Success of Ready-to-Use Packaging Components
10.4. Increasing Partnership Activity to Drive Future Growth
10.5. Overall, the Market is Anticipated to Witness Steady Growth in the Next Decade
11. INTERVIEW TRANSCRIPT(S)
12. APPENDIX 1: TABULATED DATA
13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 3.1 Advantages of Pharmaceutical Packaging
Figure 3.2 Types of Pharmaceutical Packaging
Figure 3.3 Innovation in Pharmaceutical Packaging and Value Chain
Figure 3.4 Traditional Aseptic Pharmaceutical Filling
Figure 3.5 Ready-to-Use Enabled Flexible, Aseptic Processing
Figure 3.6 Advantages of Ready-to-Use Platforms
Figure 3.7 Cost Comparison of Ready-to-Use and Conventional Container Systems
Figure 3.8 Drivers of Ready-to-Use Platform
Figure 4.1 Ready-to-Use Primary Packaging: Distribution by Type of Service / Product Offered
Figure 4.2 Ready-to-Use Primary Packaging: Distribution by Geographical Location of Manufacturer
Figure 4.3 Ready-to-Use Primary Packaging: Distribution by Type of Product
Figure 4.4 Ready-to-Use Primary Packaging: Distribution by Geographical Location of Manufacturer
Figure 4.5 Ready-to-Use Primary Packaging: Distribution by Scale of Production of Manufacturer
Figure 4.6 Ready-to-Use Containers: Distribution by Type of Container
Figure 4.7 Ready-to-Use Containers: Distribution by Fabrication Material
Figure 4.8 Ready-to-Use Closures: Distribution by Type of Container
Figure 4.9 Ready-to-Use Closures: Distribution by Sterilization Method
Figure 4.10 Ready-to-Use Container-Closure Systems: Distribution by Type of Container
Figure 4.11 Ready-to-Use Container-Closure Systems: Distribution by Fabrication Material of Containers
Figure 4.12 Ready-to-Use Packaging Processing Equipment: Distribution by Geographical Location of Manufacturer
Figure 4.13 Ready-to-Use Packaging Processing Equipment: Distribution by Type
Figure 4.14 Ready-to-Use Packaging Processing Equipment: Distribution by Type of Container
Figure 5.1 Aptar Group: Annual Revenues, 2013-H1 2018 (USD Billion)
Figure 5.2 Aptar Pharma: Annual Revenues, 2013-H1 2018 (USD Million)
Figure 5.3 Gerresheimer Group: Annual Revenues, 2013-H1 2018 (EUR Billion)
Figure 5.4 Gerresheimer, Plastics & Devices Division: Annual Revenues, 2013-H1 2018 (EUR Million)
Figure 5.5 Gerresheimer, Primary Packaging Glass Division: Annual Revenues, 2013-H1 2018 (EUR Million)
Figure 5.6 Nipro Group: Annual Revenues, 2013-2017 (JPY Billion)
Figure 5.7 SCHOTT: Annual Revenues, 2013-2017 (EUR Billion)
Figure 5.8 West Pharmaceutical Services: Annual Revenues, 2013-H1 2018 (USD Billion)
Figure 6.1 Partnerships and Collaborations: Cumulative Trend by Year, 2011-2018
Figure 6.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 6.3 Partnerships and Collaborations: Distribution by Focus Area
Figure 6.4 Partnerships and Collaborations: Most Active Players
Figure 7.1 Upcoming Trends Related to Pharmaceutical Packaging
Figure 7.2 Future Growth Opportunities of Ready-to-Use Containers and Closures Based on Recent Trends
Figure 8.1 Advantages of Robotic Systems in Pharmaceutical Manufacturing
Figure 9.1 Percentage Distribution of Processing Costs for Normal Packaging Components
Figure 9.2 Global Ready-to-Use Primary Packaging Market, 2018-2030 (USD Million)
Figure 9.3 Global Ready-to-Use Primary Packaging Market, 2018-2030 (Million Units)
Figure 9.4 Global Ready-to-Use Primary Packaging Market: Distribution by Type of Fabrication Material, 2018, 2025 and 2030
Figure 9.5 Ready-to-Use Primary Packaging Market, Share of Plastic Packaging: Base Scenario (USD Million), 2018-2030
Figure 9.6 Ready-to-Use Primary Packaging Market, Share of Plastic Packaging (Million Units), 2018-2030
Figure 9.7 Ready-to-Use Primary Packaging Market, Share of Glass Packaging: Base Scenario (USD Million), 2018-2030
Figure 9.8 Ready-to-Use Primary Packaging Market, Share of Glass Packaging (Million Units), 2018-2030
Figure 9.9 Global Ready-to-Use Primary Packaging Market: Distribution by Geography, 2018, 2025 and 2030
Figure 9.10 The US Ready-to-Use Primary Packaging Market: Base Scenario, 2018-2030 (USD Million)
Figure 9.11 The US Ready-to-Use Primary Packaging Market, 2018-2030 (Million Units)
Figure 9.12 Europe Ready-to-Use Primary Packaging Market: Base Scenario, 2018-2030 (USD Million)
Figure 9.13 Europe Ready-to-Use Primary Packaging Market Market, 2018-2030 (Million Units)
Figure 9.14 Asia Pacific Ready-to-Use Primary Packaging Market: Base Scenario, 2018-2030 (USD Million)
Figure 9.15 Asia Pacific Ready-to-Use Primary Packaging Market, 2018-2030 (Million Units)
Figure 9.16 Rest of the World Ready-to-Use Primary Packaging Market: Base Scenario, 2018-2030 (USD Million)
Figure 9.17 Rest of the World Ready-to-Use Primary Packaging Market, 2018-2030 (Million Units)
Figure 9.18 Global Ready-to-Use Primary Packaging Market: Distribution by Type of Product, 2018, 2025 and 2030
Figure 9.19 Ready-to-Use Cartidges Market: Base Scenario, 2018-2030 (USD Million)
Figure 9.20 Ready-to-Use Cartridges Market, 2018-2030 (Million Units)
Figure 9.21 Ready-to-Use Cartridges Market: Distribution by Fabrication Material, Base Scenario (USD Million)
Figure 9.22 Ready-to-Use Cartridges Market: Distribution by Geography, Base Scenario, 2018-2030 (USD Million)
Figure 9.23 Ready-to-Use Syringes Market: Base Scenario, 2018-2030 (USD Million)
Figure 9.24 Ready-to-Use Syringes Market, 2018-2030 (Million Units)
Figure 9.25 Ready-to-Use Syringes Market: Distribution by Fabrication Material, Base Scenario (USD Million)
Figure 9.26 Ready-to-Use Syringes Market: Distribution by Geography, Base Scenario (USD Million)
Figure 9.27 Ready-to-Use Vials Market: Base Scenario, 2018-2030 (USD Million)
Figure 9.28 Ready-to-Use Vials Market, 2018-2030 (Million Units)
Figure 9.29 Ready-to-Use Vials Market: Distribution by Fabrication Material, Base Scenario (USD Million)
Figure 9.30 Ready-to-Use Vials Market: Distribution by Geography, Base Scenario (USD Million)
Figure 9.31 Ready-to-Use Closures Market: Base Scenario (USD Million)
Figure 9.32 Ready-to-Use Closures Market, 2018-2030 (Million Units)
Figure 9.33 Ready-to-Use Closures Market: Distribution by Geography, Base Scenario (USD Million)
Figure 10.1 Global Ready-to-Use Primary Packaging Market: Conservative, Base and Optimistic Scenarios, 2018, 2025 and 2030 (USD Million)
Figure 10.2 Global Ready-to-Use Primary Packaging Market: Distribution by Containers and Closures, 2018, 2025 and 2030 (Million Units)
LIST OF TABLES
Table 4.1 Ready-to-Use Primary Packaging: List of Products
Table 4.2 Ready-to-Use Containers: Key Specifications
Table 4.3 Ready-to-Use Closures: Key Specifications
Table 4.4 Ready-to-Use Container-Closure Systems: Key Specifications
Table 4.5 Ready-to-Use Primary Packaging: List of Processing Equipment
Table 4.6 Ready-to-Use Primary Packaging: Key Specifications of Processing Equipment
Table 4.7 Ready-to-Use Packaging Fill / Finish Service Providers
Table 5.1 Aptar Pharma: Overview
Table 5.2 Aptar Pharma: Key Specifications of Large Volume Parenteral Stoppers
Table 5.3 Aptar Pharma: Key Specifications of Lyophilization Stoppers
Table 5.4 Aptar Pharma: Key Specifications of Plungers
Table 5.5 Aptar Pharma: Key Specifications of Small Volume Parenteral Stoppers
Table 5.6 Aptar Pharma: Key Specifications of Tip Caps
Table 5.7 AptarGroup: Future Outlook
Table 5.8 Gerresheimer Group: Overview
Table 5.9 Gerresheimer Group: Key Specifications of Gx RTF ClearJect
Table 5.10 Gerresheimer Group: Key Specifications of Gx RTF Glass Syringes
Table 5.11 Gerresheimer Group: Key Specifications of Gx RTF Needle Syringes
Table 5.12 Gerresheimer Group: Key Specifications of Gx RTF Prefillable Luer Lock Glass Syringes
Table 5.13 Gerresheimer Group: Key Specifications of Gx RTF Prefillable Luer Cone Glass Syringes
Table 5.14 Gerresheimer Group: Key Specifications of Gx InnoSafe Safety Syringes
Table 5.15 Gerresheimer Group: Key Specifications of Gx RTF Vials
Table 5.16 Gerresheimer Group: Key Specifications of Plunger Stoppers
Table 5.17 Gerresheimer Group: Future Outlook
Table 5.18 Ningbo Zhengli Pharmaceutical Packaging: Overview
Table 5.19 Ningbo Zhengli Pharmaceutical Packaging: Key Specifications of Ready-to-Use Pharmaceutical Vials
Table 5.20 Ningbo Zhengli Pharmaceutical Packaging: Key Specifications of Ready-to-Use Pharmaceutical Cartridges
Table 5.21 Ningbo Zhengli Pharmaceutical Packaging: Key Specifications of Ready-to-Use Pre-fillable Syringes
Table 5.22 Ningbo Zhengli Pharmaceutical Packaging: Key Specifications of Ready-to-Use Ampoules
Table 5.23 Ningbo Zhengli Pharmaceutical Packaging: Future Outlook
Table 5.24 Nipro PharmaPackaging: Overview
Table 5.25 Nipro PharmaPackaging: Key Specifications of D2F Syringes
Table 5.26 Nipro PharmaPackaging: Key Specifications of D2F Vials
Table 5.27 Nipro PharmaPackaging: Key Specifications of Stoppers (for Vials)
Table 5.28 Nipro PharmaPackaging: Future Outlook
Table 5.29 Ompi: Overview
Table 5.30 Ompi: Key Specifications of EZ-fill Cartridges
Table 5.31 Ompi: Key Specifications of EZ-fill Vials
Table 5.32 Ompi: Key Specifications of EZ-fill Syringes
Table 5.33 Ompi: Key Specifications of ISS Syringes
Table 5.34 Ompi: Key Specifications of LDP Vials
Table 5.35 Ompi: Key Specifications of ITC Syringes
Table 5.36 Ompi: Key Specifications of Plungers
Table 5.37 Stevanato Group: Future Outlook
Table 5.38 SCHOTT: Overview
Table 5.39 SCHOTT: Key Specifications of adaptiQ
Table 5.40 SCHOTT: Key Specifications of syriQ
Table 5.41 SCHOTT: Key Specifications of SCHOTT TopPac
Table 5.42 SCHOTT: Key Specifications of syriQ BioPure
Table 5.43 SCHOTT: Future Outlook
Table 5.44 West Pharmaceutical Services: Overview
Table 5.45 West Pharmaceutical Services: Key Specifications of Daikyo Crystal Zenith Cartridges
Table 5.46 West Pharmaceutical Services: Key Specifications of Daikyo Crystal Zenith Vials
Table 5.47 West Pharmaceutical Services: Key Specifications of Daikyo Crystal Zenith Insert Needle Syringe Systems
Table 5.48 West Pharmaceutical Services: Key Specifications of Daikyo Crystal Zenith Luer Lock Syringe Systems
Table 5.49 West Pharmaceutical Services: Key Specifications of Westar Select Cartridge Plungers
Table 5.50 West Pharmaceutical Services: Key Specifications of Westar RU Cartridge Plungers
Table 5.51 West Pharmaceutical Services: Key Specifications of Westar RU Lined Seals
Table 5.52 West Pharmaceutical Services: Key Specifications of NovaPure Syringe Plungers
Table 5.53 West Pharmaceutical Services: Key Specifications of FluroTec Plungers
Table 5.54 West Pharmaceutical Services: Key Specifications of Envision Plungers
Table 5.55 West Pharmaceutical Services: Key Specifications of Westar Syringe Plungers
Table 5.56 West Pharmaceutical Services: Key Specifications of Westar Select Syringe Plungers
Table 5.57 West Pharmaceutical Services: Key Specifications of Rigid and Soft Needle Shields and Tip Caps
Table 5.58 West Pharmaceutical Services: Key Specifications of Envision Stoppers
Table 5.59 West Pharmaceutical Services: Key Specifications of Flip-Off CCS Seals
Table 5.60 West Pharmaceutical Services: Key Specifications of Flip-Off Plus RU Seals
Table 5.61 West Pharmaceutical Services: Key Specifications of FluroTec Barrier Film Stoppers
Table 5.62 West Pharmaceutical Services: Key Specifications of LyoTec Stoppers
Table 5.63 West Pharmaceutical Services: Key Specifications of LyoSeal Caps
Table 5.64 West Pharmaceutical Services: Key Specifications of NovaPure Stoppers
Table 5.65 West Pharmaceutical Services: Key Specifications of Westar RU Stoppers
Table 5.66 West Pharmaceutical Services: Key Specifications of West Spectra Seals
Table 5.67 West Pharmaceutical Services: Key Specifications of West Ready Pack System
Table 5.68 West Pharmaceutical Services: Future Outlook
Table 6.1 Ready-to-Use Primary Packaging: Partnerships and Collaborations, 2011-2018
Table 8.1 Robotic Systems for Pharmaceutical Industry: List of Manufacturers
Table 8.2 Aseptic Technologies: Overview
Table 8.3 Key Specifications of Crystal L1 Robot Line
Table 8.4 Key Specifications of Crystal SL1 Robot Line
Table 8.5 AST: Overview
Table 8.6 Key Specifications of ASEPTiCell Series
Table 8.7 Key Specifications of ASEPTiCell VSM-25
Table 8.8 Bosch Packaging Technology: Overview
Table 8.9 Key Specifications of ATO
Table 8.10 Dara Pharmaceutical Packaging: Overview
Table 8.11 Key Specifications of SYX-E CARTRIDGE + RABS
Table 8.12 Fedegari Group: Overview
Table 8.13 Key Specifications of Fedegari Isolator
Table 8.14 IMA: Overview
Table 8.15 Key Specifications of INJECTA
Table 8.16 Key Specifications of STERI LIF3
Table 8.17 Steriline: Overview
Table 8.18 Key Specifications of Nest Filling Line RNFM
Table 8.19 Vanrx Pharmasystems: Overview
Table 8.20 Key Specifications of Microcell Vial Filler
Table 8.21 Key Specifications of SA25 Aseptic Filling Workcells
Table 12.1 Ready-to-Use Primary Packaging: Distribution of by Type of Service / Product Offered
Table 12.2 Ready-to-Use Primary Packaging: Distribution by Geographical Location of Manufacturer
Table 12.3 Ready-to-Use Primary Packaging: Distribution by Type of Product
Table 12.4 Ready-to-Use Primary Packaging: Distribution by Geographical Location of Manufacturer
Table 12.5 Ready-to-Use Primary Packaging: Distribution by Scale of Production of Manufacturer
Table 12.6 Ready-to-Use Containers: Distribution by Type of Container
Table 12.7 Ready-to-Use Containers: Distribution by Fabrication Material
Table 12.8 Ready-to-Use Closures: Distribution by Type of Container
Table 12.9 Ready-to-Use Closures: Distribution by Sterilization Method
Table 12.10 Ready-to-Use Container-Closure Systems: Distribution by Container
Table 12.11 Ready-to-Use Container-Closure Systems: Distribution by Fabrication Material of Container
Table 12.12 Ready-to-Use Equipment Manufacturers: Distribution by Geographical Location of Manufacturer
Table 12.13 Ready-to-Use Packaging Processing Equipment: Distribution by Type
Table 12.14 Ready-to-Use Packaging Processing Equipment: Distribution by Type of Container
Table 12.15 AptarGroup: Annual Revenues, 2013-H1 2018 (USD Billion)
Table 12.16 Aptar Pharma: Annual Revenues, 2013-H1 2018 (USD Million)
Table 12.17 Gerresheimer Group: Annual Revenues, 2013-H1 2018 (EUR Billion)
Table 12.18 Gerresheimer, Plastics & Devices Division: Annual Revenues, 2013-H1 2018 (EUR Million)
Table 12.19 Gerresheimer, Primary Packaging Glass Division: Annual Revenues, 2013-H1 2018 (EUR Million)
Table 12.20 Nipro Group: Annual Revenues, 2013-2017 (JPY Billion)
Table 12.21 SCHOTT: Annual Revenues, 2013-2017 (EUR Billion)
Table 12.22 West Pharmaceutical Services: Annual Revenues, 2013-H1 2018 (USD Billion)
Table 12.23 Partnerships and Collaborations: Cumulative Trend by Year, 2011-2018
Table 12.24 Partnerships and Collaborations: Distribution by Type of Partnership
Table 12.25 Partnerships and Collaborations: Distribution by Focus Area
Table 12.26 Partnerships and Collaborations: Most Active Players
Table 12.27 Percentage Distribution of Processing Costs for Normal Packaging Components
Table 12.28 Global Ready-to-Use Primary Packaging Market, Conservative, Base and Optimistic Scenarios, 2018-2030 (USD Million)
Table 12.29 Global Ready-to-Use Primary Packaging Market, 2018-2030 (Million Units)
Table 12.30 Global Ready-to-Use Primary Packaging Market: Distribution by Type of Fabrication Material, 2018, 2025 and 2030
Table 12.31 Ready-to-Use Primary Packaging Market, Share of Plastic Packaging: Conservative, Base and Optimistic Scenarios (USD Million), 2018-2030
Table 12.32 Ready-to-Use Primary Packaging Market, Share of Plastic Packaging (Million Units), 2018-2030
Table 12.33 Ready-to-Use Primary Packaging Market, Share of Glass Packaging: Conservative, Base and Optimistic Scenarios (USD Million), 2018-2030
Table 12.34 Ready-to-Use Primary Packaging Market, Share of Glass Packaging (Million Units), 2018-2030
Table 12.35 Global Ready-to-Use Primary Packaging Market: Distribution by Geography, 2018, 2025 and 2030
Table 12.36 The US Ready-to-Use Primary Packaging Market: Conservative, Base and Optimistic Scenarios, 2018-2030 (USD Million)
Table 12.37 The US Ready-to-Use Primary Packaging Market, 2018-2030 (Million Units)
Table 12.38 Europe Ready-to-Use Primary Packaging Market: Conservative, Base and Optimistic Scenarios, 2018-2030 (USD Million)
Table 12.39 Europe Ready-to-Use Primary Packaging Market, 2018-2030 (Million Units)
Table 12.40 Asia Pacific Ready-to-Use Primary Packaging Market: Conservative, Base and Optimistic Scenarios, 2018-2030 (USD Million)
Table 12.41 Asia Pacific Ready-to-Use Primary Packaging Market, 2018-2030 (Million Units)
Table 12.42 Rest of the World Ready-to-Use Primary Packaging Market: Base Scenario, 2018-2030 (USD Million)
Table 12.43 Rest of the World Ready-to-Use Primary Packaging Market, 2018-2030 (Million Units)
Table 12.44 Global Ready-to-Use Primary Packaging Market: Distribution by Type of Product, 2018, 2025 and 2030
Table 12.45 Ready-to-Use Cartridges Market: Conservative, Base and Optimistic Scenarios, 2018-2030 (USD Million)
Table 12.46 Ready-to-Use Cartridges Market, 2018-2030 (Million Units)
Table 12.47 Ready-to-Use Cartridges Market: Distribution by Fabrication Material, Conservative, Base and Optimistic Scenarios (USD Million)
Table 12.48 Ready-to-Use Cartridges Market: Distribution by Geography, Conservative Scenario (USD Million)
Table 12.49 Ready-to-Use Cartridges Market: Distribution by Geography, Base Scenario (USD Million)
Table 12.50 Ready-to-Use Cartridges Market: Distribution by Geography, Optimistic Scenario (USD Million)
Table 12.51 Ready-to-Use Syringes Market: Conservative, Base and Optimistic Scenarios, 2018-2030 (USD Million)
Table 12.52 Ready-to-Use Syringes Market, 2018-2030 (Million Units)
Table 12.53 Ready-to-Use Syringes Market: Distribution by Fabrication Material, Conservative, Base and Optimistic Scenarios (USD Million)
Table 12.54 Ready-to-Use Syringes Market: Distribution by Geography, Conservative Scenario (USD Million)
Table 12.55 Ready-to-Use Syringes Market: Distribution by Geography, Base Scenario (USD Million)
Table 12.56 Ready-to-Use Syringes Market: Distribution by Geography, Optimistic Scenario (USD Million)
Table 12.57 Ready-to-Use Vials Market: Conservative, Base and Optimistic Scenarios, 2018-2030 (USD Million)
Table 12.58 Ready-to-Use Vials Market, 2018-2030 (Million Units)
Table 12.59 Ready-to-Use Vials Market: Distribution by Fabrication Material, Conservative, Base and Optimistic Scenarios (USD Million)
Table 12.60 Ready-to-Use Vials Market: Distribution by Geography, Conservative Scenario (USD Million)
Table 12.61 Ready-to-Use Vials Market: Distribution by Geography, Base Scenario (USD Million)
Table 12.62 Ready-to-Use Vials Market: Distribution by Geography, Optimistic Scenario (USD Million)
Table 12.63 Ready-to-Use Closures Market: Conservative, Base and Optimistic Scenarios (USD Million)
Table 12.64 Ready-to-Use Closures Market, 2018-2030 (Million Units)
Table 12.65 Ready-to-Use Closures Market: Distribution by Geography, Conservative Scenario (USD Million)
Table 12.66 Ready-to-Use Closures Market: Distribution by Geography, Base Scenario (USD Million)
Table 12.67 Ready-to-Use Closures Market: Distribution by Geography, Optimistic Scenario (USD Million)
Table 12.68 Global Ready-to-Use Primary Packaging Market: Conservative, Base and Optimistic Scenarios, 2018, 2025 and 2030 (USD Million)
Table 12.69 Global Ready-to-Use Primary Packaging Market: Distribution by Containers and Closures, 2018, 2025 and 2030 (Million Units)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report